Anna Brouwer

ERG abnormalities in non-anterior childhood uveitis References 1. Kalinina Ayuso V, ten Cate HAT, van den Does P, Rothova A, de Boer JH. Young age as a risk factor for complicated course and visual outcome in intermediate uveitis in children. Br J Ophthalmol . 2011;95(5):646-651. doi:10.1136/bjo.2010.184267 2. de Boer J, Berendschot TTJM, van der Does P, Rothova A. Long-term follow-up of intermediate uveitis in children. Am J Ophthalmol . 2006;141(4):616-621. doi:10.1016/j. ajo.2005.09.035 3. Hettinga YM, Verhagen FH, van Genderen M, de Boer JH. Characteristics of childhood uveitis leading to visual impairment and blindness in the Netherlands. Acta Ophthalmol . 2014;92(8):798-804. doi:10.1111/aos.12491 4. de Smet MD, Taylor SRJ, Bodaghi B, et al. Understanding uveitis: the impact of research on visual outcomes. Prog Retin Eye Res . 2011;30(6):452-470. doi:10.1016/j. preteyeres.2011.06.005 5. Moschos MM, Gouliopoulos NS, Kalogeropoulos C. Electrophysiological examination in uveitis: a review of the literature. Clin Ophthalmol . 2014;8:199-214. doi:10.2147/OPTH.S54838 6. Tzekov R, Madow B. Visual Electrodiagnostic Testing in Birdshot Chorioretinopathy. J Ophthalmol . 2015;2015:680215. doi:10.1155/2015/680215 7. Zacks DN, Samson CM, Loewenstein J, Foster CS. Electroretinograms as an indicator of disease activity in birdshot retinochoroidopathy. Graefes Arch Clin Exp Ophthalmol . 2002;240(8):601-607. doi:10.1007/s00417-002-0506-7 8. Holder GE, Robson AG, Pavesio C, Graham EM. Electrophysiological characterisation and monitoring in the management of birdshot chorioretinopathy. Br J Ophthalmol . 2005;89(6):709-718. doi:10.1136/bjo.2004.047837 9. Shamshinova AM, Katargina LA, Orlovskaya LS. Electroretinographic findings in children with uveitis. In: Dernouchamps JP, Verougstraete C, Caspers-Velu L, Tassignon MJ, eds. Recent Advances in Uveitis . Kugler Publications, Amsterdam/ New York; 1992:397-400. 10. Hettinga YM, van Genderen MM, Wieringa W, Ossewaarde-van Norel J, de Boer JH. Retinal Dystrophy in 6 Young Patients Who Presented with Intermediate Uveitis. Ophthalmology . 2016;123(9):2043-2046. doi:10.1016/j.ophtha.2016.03.046 11. Jabs D a. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol . 2005;140(3):509-516. doi:10.1016/j. ajo.2005.03.057 12. McCulloch DL, Marmor MF, Brigell MG, et al. ISCEV Standard for full-field clinical electroretinography (2015 update). Doc Ophthalmol . 2015;130(1):1-12. doi:10.1007/ s10633-014-9473-7 13. Tugal-Tutkun I, Herbort CP, Khairallah M. Scoring of dual fluorescein and ICG inflammatory angiographic signs for the grading of posterior segment inflammation (dual fluorescein and ICG angiographic scoring system for uveitis). Int Ophthalmol . 2010;30(5):539-552. doi:10.1007/s10792-008-9263-x 14. Sarens IL, Casteels I, Anton J, et al. Blau Syndrome-Associated Uveitis: Preliminary Results From an International Prospective Interventional Case Series. Am J Ophthalmol . 2018;187:158-166. doi:10.1016/j.ajo.2017.08.017 15. Jonas JB, Schneider U, Naumann GO. Count and density of human retinal photoreceptors. Graefes Arch Clin Exp Ophthalmol . 1992;230(6):505-510. 121 5